gr 73632 has been researched along with Astrocytoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arkinstall, S; Beresford, IJ; Hagan, RM; Ireland, SJ; Seale, PW; Stables, JM; Walsh, DM; Ward, P | 1 |
Bauer, J; Berger, M; Fiebich, BL; Lieb, K; Schulze-Osthoff, K | 1 |
2 other study(ies) available for gr 73632 and Astrocytoma
Article | Year |
---|---|
GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors.
Topics: Amino Acid Sequence; Animals; Arachidonic Acid; Astrocytoma; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Humans; Male; Molecular Sequence Data; Neurokinin B; Oligopeptides; Peptide Fragments; Portal Vein; Rats; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Substance P; Transfection; Tumor Cells, Cultured | 1994 |
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells.
Topics: Astrocytoma; Calcium; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Intracellular Fluid; Neurokinin-1 Receptor Antagonists; NF-kappa B; Peptide Fragments; RNA, Messenger; Substance P; Time Factors; Tumor Cells, Cultured | 1997 |